首页> 外文期刊>GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW >Results after surgical treatment of periprosthetic proximal femoral fractures. Osteosynthesis with prosthesis preservation vs. prosthesis change
【24h】

Results after surgical treatment of periprosthetic proximal femoral fractures. Osteosynthesis with prosthesis preservation vs. prosthesis change

机译:结果近端股骨骨折手术治疗后。具有假体保存的骨质化与假体变化

获取原文
           

摘要

Background: Periprosthetic fractures (PPF) of the femur close to the hip joint have serious consequences for most geriatric affected patients. In principle, apart from the highly uncommon conservative therapy, there are two therapeutic options. On the one hand, the prosthesis-preserving treatment by means of osteosynthesis using plates and/or cerclages in general is available. On the other hand, a (partial) change of the prosthesis with optionally additive osteosynthesis or a proximal femoral replacement can be performed because of prosthesis loosening or non-reconstructable comminuted fractures as well as most cemented stem variations. The aim of this retrospective study is the analysis of periprosthetic proximal femoral fractures in the presence of a total hip arthroplasty (THA). The outcome of the operated patients is to be investigated depending on the type of care (osteosynthesis with prosthesis preservation vs. prosthesis change). Material and methods: In a retrospective case analysis, 80 patients with THA and PPF were included. They were divided into two groups. Group I represents the osteosynthetic treatment to preserve the implanted THA (n=42). Group II (n=38) includes those patients who were treated by a change of their endoprosthesis with or without additional osteosynthesis. Specifics of all patients, like gender, age at fracture, interval between fracture and implantation, length of in-patient stay, body mass index, osteoporosis, corticomedullary index and complications such as infections, re-fracture, loosening, material failure or other complications, were recorded and compared. Furthermore, the patients were re-examined by a questionnaire and the score according to Merle d’Aubigné and Postel. Results: In group I the mean follow-up time was 48.5±23 months (4 y ears) whereas group II amounted 32.5±24.5 months (2.7 years) (p=0.029). Besides, there were significant differences in age (81± 1 1 y ears vs. 76±10 years, p=0.047) and length of in-patient stay (14.5±8.6 days vs. 18.0±16.7 days, p=0.014). According to the score of Merle d’Aubigné and Postel, there were significantly better values for the pain in group II with comparable values for mobility and walking ability. Conclusion: The treatment of periprosthetic proximal fractures of the femur is dependent on the classification (Vancouver and Johannsen) and in particular on the prosthetic anchoring as well as the extent of the comminution zone. Older patients and patients with osteoporosis are more frequently treated with an endoprosthesis revision. Patients, who have been treated with an osteosynthesis for preserving their endoprosthesis, showed a shorter length of in-patient stay and fewer complications than people with replacement surgery. In contrast to that, patients with prosthesis revision had better outcomes concerning the score of Merle d’Aubigné and Postel.
机译:背景:髋关节接近髋关节的股骨骨折(PPF)对大多数老年受影响的患者具有严重后果。原则上,除了高度罕见的保守疗法外,还有两种治疗选择。一方面,通过骨合成使用平板和/或塞尔格的骨性合成的假体保留处理可用。另一方面,由于假体松动或不可重建的粉碎骨折以及大多数粘合的茎变化,可以进行(部分)假体的(部分)变化或近端股骨替换。该回顾性研究的目的是在总髋关节置换术(THA)存在下对近端雌性骨折的分析。经营患者的结果是根据护理类型进行调查(骨质合成与假体保存的骨质变化)。材料和方法:在回顾性案例分析中,包括80例患者和PPF患者。他们分为两组。 I族代表骨质合成治疗以保留植入的THA(n = 42)。 II族(N = 38)包括那些因其内或没有额外骨质合成的内置调节而受到治疗的患者。所有患者的细节,如性别,骨折时的年龄,骨折和植入之间的间隔,患者患者的长度,体重指数,骨质疏松症,皮质体指数和并发症,如感染,再骨折,松动,物质衰竭或其他并发症,被记录并进行比较。此外,根据Merle D'Aubigné和帖子,通过调查问卷和分数重新检查患者。结果:在群中,平均随访时间为48.5±23个月(4耳),而第II族则为32.5±24.5个月(2.7岁)(P = 0.029)。此外,年龄差异有显着差异(81±1 1耳与76±10年,P = 0.047)和患者长度(14.5±8.6天与18.0±16.7天,P = 0.014)。根据Merle D'Aubigné和帖子的得分,具有相当于移动性和行走能力的可比价值观的疼痛的显着更好的价值。结论:股骨近侧骨折的治疗取决于分类(温哥华和约翰森),特别是对假体锚定以及粉碎区的范围。患者和骨质疏松症的患者更频繁地用内华松体验修订治疗。已经用骨质合成治疗的患者进行治疗内置后的患者,表明,比替代手术的人患者的患者保持较短,并发症较少。与此相反,假体修订的患者有关Merle D'Aubigné和帖子的得分更好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号